Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study

BACKGROUND: Orally administered bisphosphonate drugs (i.e., alendronate, etidronate, risedronate) can reduce the risk of vertebral fracture. However, only alendronate and risedronate have proven efficacy in reducing the risk of hip fracture. We sought to examine the comparative effectiveness of oral...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cadarette, Suzanne M., Lévesque, Linda, Mamdani, Muhammad, Perreault, Sylvie, Juurlink, David N., Paterson, J. Michael, Carney, Greg, Gunraj, Nadia, Hawker, Gillian A., Tadrous, Mina, Wong, Lindsay, Dormuth, Colin R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Canadian Medical Association 2013
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986012/
https://ncbi.nlm.nih.gov/pubmed/25077113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20130036
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller